Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-26 Sale |
2022-08-29 9:11 pm |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
13,379 | $4.0105 | $53,656 | 908,778 (Indirect Direct) |
View |
| 2022-05-26 Sale |
2022-05-27 5:34 pm |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
13,162 | $1.9011 | $25,022 | 922,157 (Indirect Direct) |
View |
| 2022-02-28 Sale |
2022-03-01 9:13 pm |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
14,635 | $2.7795 | $40,678 | 935,319 (Indirect Direct) |
View |
| 2021-11-26 Sale |
2021-11-29 7:46 pm |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
27,747 | $4.8112 | $133,495 | 942,954 (Indirect Direct) |
View |
| 2021-11-15 Purchase |
2021-11-15 5:59 pm |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
8,000 | $5.56 | $44,480 | 567,198 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-25 Exercise |
2024-11-27 4:08 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
25,219 | $0 | 908,778 (Direct) |
View |
| 2024-08-25 Exercise |
2024-09-12 6:13 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
25,219 | $0 | 908,778 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 7:50 pm |
N/A 2034-06-20 |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-05-25 Exercise |
2024-05-29 7:07 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
25,219 | $0 | 908,778 (Direct) |
View |
| 2024-02-25 Exercise |
2024-02-27 7:58 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
25,219 | $0 | 908,778 (Direct) |
View |
| 2023-11-25 Exercise |
2023-11-28 7:03 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
25,219 | $0 | 908,778 (Direct) |
View |
| 2023-08-25 Exercise |
2023-08-29 6:52 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
25,219 | $0 | 908,778 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 6:34 pm |
N/A 2033-06-08 |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-05-25 Exercise |
2023-05-26 7:32 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
25,219 | $0 | 908,778 (Direct) |
View |
| 2023-02-25 Exercise |
2023-02-28 6:30 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
25,219 | $0 | 908,778 (Direct) |
View |
| 2022-11-25 Exercise |
2022-11-29 5:18 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
25,219 | $0 | 908,778 (Direct) |
View |
| 2022-07-08 Option Award |
2022-09-08 2:32 pm |
N/A 2032-07-07 |
BIOCEPT INC | BIOC | ROYSTON IVOR Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-08-25 Exercise |
2022-08-29 9:11 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
25,219 | $0 | 908,778 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 5:34 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
25,219 | $0 | 922,157 (Direct) |
View |
| 2022-03-17 Option Award |
2022-03-18 5:32 pm |
N/A 2032-03-17 |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
412,500 | $0 | 412,500 (Direct) |
View |
| 2022-02-25 Exercise |
2022-03-01 9:13 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
25,219 | $0 | 935,319 (Direct) |
View |
| 2021-12-29 Exercise |
2021-12-30 6:47 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
7,000 | $0.9 | 657,688 (Direct) |
View |
| 2021-12-29 Exercise |
2021-12-30 6:47 pm |
N/A 2029-02-13 |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
7,000 | $0 | 657,688 (Direct) |
View |
| 2021-11-25 Exercise |
2021-11-29 7:46 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
50,437 | $0 | 942,954 (Direct) |
View |
| 2021-07-16 Option Award |
2021-07-20 4:42 pm |
N/A 2031-07-15 |
BIOCEPT INC | BIOC | ROYSTON IVOR Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 8:03 pm |
N/A 2031-03-26 |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
441,993 | $0 | 441,993 (Direct) |
View |
Ownership |
2021-02-24 7:31 pm |
N/A N/A |
SUNESIS PHARMACEUTICALS INC | VIRX | ROYSTON IVOR CEO & President |
0 | $0 | 1,232,252 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-09 2:25 pm |
N/A 2030-06-04 |
BIOCEPT INC | BIOC | ROYSTON IVOR Director |
500 | $0 | 500 (Direct) |
View |